| CTRI Number |
CTRI/2025/09/094375 [Registered on: 08/09/2025] Trial Registered Prospectively |
| Last Modified On: |
04/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia Laciniosa) churna in the manegement of PCOS |
|
Scientific Title of Study
|
Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia laciniosa) churna in the manegement of PCOS |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
VD PRASHANT DALVI |
| Designation |
PhD scholerscholar |
| Affiliation |
Associate Professor, R A Podar Medical College AYU, |
| Address |
Departmnet of Prasutitantra and Streeroga, Dr D. Y. Patil College of Ayurved and Research centre, Pimpari, Pune, 411018 R A Podar Medical College AYU, Annebezant road, Worli,Mumbai Mumbai MAHARASHTRA 411018 India |
| Phone |
9822783636 |
| Fax |
|
| Email |
drdalvipn@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
VD PRASHANT DALVI |
| Designation |
PhD Scholar |
| Affiliation |
Associate Professor, R. A. Podar Medical College AYU, |
| Address |
Departmnet of Prasutitantra and Streeroga, Dr D. Y. Patil College of Ayurved and Research centre, Pimpari, Pune, 411018 R A Podar Medical College AYU, Annebezant road, Worli, Mumbai Mumbai MAHARASHTRA 411018 India |
| Phone |
9822783636 |
| Fax |
|
| Email |
drdalvipn@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
VD PRASHANT DALVI |
| Designation |
PhD Scholar |
| Affiliation |
Associate Professor, R A Podar Medical College AYU, Worli, Mumbai |
| Address |
Dr D. Y. Patil College of Ayurved and Research centre, Pimpari, Pune, 411018 R A Podar Medical College AYU, Annebezant road, Worli, Mumbai Mumbai MAHARASHTRA 411018 India |
| Phone |
9822783636 |
| Fax |
|
| Email |
drdalvipn@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr D. Y. Patil College of Ayurved Hospital, Pimpari, Pune 411018 |
|
|
Primary Sponsor
|
| Name |
Dr D Y Patil College of Ayurved Hospital Pimpari Pune |
| Address |
Pimpari Pune 411028 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Prashant Dalvi |
Dr D Y Patil Ayurved Hospital |
OPd and IPD, Department of Prasutitantra and Streeroga,Dr D Y Patil Ayurved Hospital,Pimpari,
Pune 411018 Pune MAHARASHTRA |
9822783636
drdalvipn@gmail.com |
| Dr Prashant Dalvi |
R. A. Podar Medical College and Hospital |
Annebezant road, Worli, Mumbai Mumbai MAHARASHTRA |
9822783636
drdalvipn@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| Dr. D. Y. Patil College of Ayurved And reasearch centre, Pimpari Pune |
Approved |
| IEC R A Podar Medical College AYU |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:O||Medical and Surgical. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Comparator Arm (Non Ayurveda) | | - | Tab. Metformin | 500 mg OD
Pragbhakta/ before meals
3 months
Oral
Monthly
| | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Shivlingi beeja churna, Reference: 10. Deepak Acharya, Shivlingi: A Common but Important Twine in Patalkot. Ame Chronicle, Dec 18: 2006, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -koshna jal), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
19.00 Year(s) |
| Age To |
35.00 Year(s) |
| Gender |
Female |
| Details |
Married Unmarried Both.
PCOS diagnosed by Rotterdam crieteria 2/3 |
|
| ExclusionCriteria |
| Details |
Patients showing signs and symptoms other than PCOS
Patients having any other disease causing Oligomenorrhea and Anovulation excluding PCOS on above criteria i.e. Hypogonadotrophic Hypogonadism, Premature Ovarian Failure.
4. Patients suffering from a) Congenital Adrenal Hyperplasia b) Severe Insulin resistance (Insulin dependent Diabetes Mellitus) c) Androgen secreting Ovarian and Adrenal tumors d) Thyroid abnormalities e) Cushing’s syndrome f) Cardiac disease g) Hyperprolactemia.
Patients with any organic lesions of Reproductive Tract like TB, Ca, Congenital anomalies, any other pelvic pathologies.
A current or previous (within 3 months) use of OC Pills, Glucocorticoids, Antiandrogens, Antidiabetics, Antiobesity drugs or any Hormonal Therapy. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Regularisation of menstrual cycle |
Regularisation of menstrual cycle after 90 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| effect of Shivlingi beeja churna on Insulin resistance |
Sr Inshulin levels |
| Change in BMI |
BMI calculated |
|
|
Target Sample Size
|
Total Sample Size="140" Sample Size from India="140"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
15/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
15/09/2025 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
“RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF THE SHIVLINGI BEEJA (BRYONIA LACINIOSA ) CHURNA IN THE
MANEGEMENT OF PCOS.”
Introduction:
PCOS is one of the most
common reproductive endocrinological disorder with a broad spectrum of clinical
manifestations affecting 8 to 10%1.2 in reproductive age group. In
PCOS ovaries fail to develops a mature egg and generate only multiple immature
follicles with increase in ovarian size represented by oligomenorrhoea or amenorrhea,
hyperandrogenism (Clinical Or Biochemical) and polycystic ovaries in USG which
is diagnosed by Rotterdam Criteria (2003)3. The pathogenesis of PCOS
is still largely unknown and until now medical care of these subjects has been
limited to symptomatic control of cosmetic concerns, menstrual dysfunctions and
infertility. Women with the syndrome are frequently insulin resistant,
independent of obesity14. In these regards, much of the data
supports that insulin resistance and the associated hyperinsulinemia plays an
important role in PCOS. Insulin has direct effect on ovarian steroidogenesis
stimulating androgen synthesis in theca cells leading to the syndrome7,15. In Ayurvedic classics,
PCOS maybe consider under various headings as Artavakshaya, Anartava,
Nashtartava, Granthibhoota Artavdushti, Vandhyatva Yonivyapada, and
Santarpanottha strotodushti. Pushpaghni Jataharini described in Kashyapa Samhita Khilsthana is the
entity which is found more resembling with symptoms of PCOS amongst the others5. Pushpaghni represents with typical features that includes destruction of Pushpa with regular menstruation, appearance of facial hair and obesity9. PCOS can be considered
as a condition manifested due to Mithyachara,
Pradushtartava Beeja Dosha4.It
may be term as Vata Kaphaja artva dushti. It is a Santarpanottha vikara with
Sanga, Avarana and Siragranthi form of pathogenesis. As the pathogenic
factors involved in PCOS are Vata and
Kapha Doshas Rasa and Meda – Dushyas, Artavavaha Strotas, Jatharagni and
Dhatvagnimandya and will need
Vatakaphaghna and Rasayan Chikitsa as one of the way for sampraptibhanga. Currently the standard
care treatment for women with PCOS ranges from lifestyle modifications to
pharmacological interventions including Anti androgens (Spironolactone, Flutamide),
Insulin lowering agents (Metformin, Thiazolidine)8 and Oral
Contraceptives as a single or combined17. Though effective, they do
not abolish the basic problem and treatment is also associated with various
adverse effects such as irregular menstruation, gastrointestinal disturbances,
weight gain.
Considering all above
points from various research papers found that “Shivlingi beeja” working on
male as well as female infertility. Scientific research need was expressed by
various authors in their review articles. As per data present role of Shivlingi
beeja was studied on male rats, which shows good results. Every paper says it
works on females also but such research is not done. As per tribes of Pakalkot
these seeds are to be use in females those wants to concive.10 So it
has been decided to work on Shivlingi beeja. According to Ayurvedic texts
Shivlingi beeja has properties like uterine tonic, Rasayana, anti-obesity and
antidiabetic properties. So with the hypothesis on the basis of available
literature, Herbal or Herbomineral medicines according to Ayurveda can have
great benefit in PCOS to abolish basic problem without or minimal adverse
effect of conventional drugs. So it is decided to study the effect of the Shivlingi beeja (bryonia laciniosa )
churna in PCOS.
Purpose of the study:
Purpose of present study is
to Study the efficacy of Shivlingi
beeja churna vati in patients
with PCOS.
Expected duration of study and expected number of participants:
140
participants and each participant will be studied for 3 months.
|
Sr.No.
|
|
Group A
|
Group B
|
|
1.
|
Drug
|
Shivlingi beeja churna
|
Tab.
Metformin
|
|
2.
|
Dose
|
3 gms OD
Luke warm
water
|
500 mg OD
|
|
3.
|
Kala
|
Pragbhakta
|
Pragbhakta
|
|
4.
|
Duration of therapy
|
3 months
|
3 months
|
|
5.
|
Route of Administration
|
Oral
|
Oral
|
|
6.
|
Follow up
|
Monthly
|
Monthly
|
Criteria of Assessment: Assessment will be done based on following
criteria before and after the treatment. Subjective criteria:
|
Menstrual cycle:
|
Interval
between 2 cycles.
|
|
Hirsutism19,20,21:
|
Modified
Ferrimen and Galley Visual Scoring System*
|
Objective
|
Sr.Insulin(F)7,14,15
|
|
BSL(F)14
|
|
Insulin Resistance
|
|
Sr.Testesterone7,14,15
|
|
PCOS Pattern and Ovarian Volume
|
|
BMI (kg/m2 )18
|
Observational criteria:
1: Grading for interval between two menstrual cycles 2: Assessment of Hirsutism
with Modified Ferriman and Galley Visual Scoring System19. 3: Assessment of variable
BMI(Kg/m2)18 4: For Variable Sr. Insulin(F) 5: For variable Sr. Testesterone 6: For Variable BSL(F) 7: For Variable Ovarian Volume 8: For PCOS Pattern
(Present or Absent)
|